Azitra (AZTR) Assets Average (2023 - 2026)
Azitra's (AZTR) quarterly Assets Average came in at $8.6 million in Q1 2026, up 29.29% YoY from $6.6 million in Q1 2025, and up 83.92% on a QoQ basis from $4.7 million in Q4 2025.
Azitra (AZTR) Assets Average (2023 - 2026) Analysis & Trends
Azitra (AZTR) has 4 years of Assets Average data on file, last reported at $8.6 million in Q1 2026.
- Quarterly Assets Average rose 29.29% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 29.29% YoY) and the FY2025 annual result came in at $6.2 million, down 0.72% from the prior year.
- Assets Average climbed to $8.6 million in Q1 2026, from $4.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $8.7 million in Q3 2023 to a low of $4.1 million in Q3 2025.
- A 4-year average of $6.4 million and a median of $6.3 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average jumped 35.94% — and 2025, when it slumped 45.58%.
- Tracing AZTR's Assets Average over 4 years: stood at $6.3 million in 2023, then jumped by 35.94% to $8.6 million in 2024, then tumbled by 45.58% to $4.7 million in 2025, then jumped by 83.92% to $8.6 million in 2026.
- The last three Assets Average figures came in at $8.6 million (Q1 2026), $4.7 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 19.82 Bn |
| 10 | Azitra | 2.54 Mn | 2.54 Mn | - | 10.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.52 Mn |
| Mar 31, 2026 | 8.58 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 8.57 Mn |
| Sep 30, 2024 | 6.83 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 5.59 Mn |
| Dec 31, 2023 | 6.30 Mn |
| Sep 30, 2023 | 8.66 Mn |